These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10463481)

  • 21. Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer.
    Ray A; Sharma BK; Kaur S; Sharma S; Sharma JK
    Indian J Exp Biol; 2004 Mar; 42(3):253-8. PubMed ID: 15233293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Kasumi F; Sawabe M; Arai T; Hosoi T; Yoshimura N; Harada N; Younes M; Sakamoto G
    Histopathology; 2007 Mar; 50(4):425-33. PubMed ID: 17448017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
    Mentrikoski MJ; Wick MR
    Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions.
    Tanaka A; Kamiakito T; Takayashiki N; Sakurai S; Saito K
    Virchows Arch; 2002 Oct; 441(4):380-4. PubMed ID: 12404063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
    Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
    Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.
    Lumachi F; Ermani M; Marino F; Di Cristofaro L; Tombolan V; Brunello A; Roma A; Basso U
    Anticancer Res; 2008; 28(1B):491-3. PubMed ID: 18383890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors for epidermal growth factor in human mammary carcinomas and their metastases.
    Macias A; Azavedo E; Perez R; Rutqvist LE; Skoog L
    Anticancer Res; 1986; 6(4):849-51. PubMed ID: 3019225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
    Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
    Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of estrogen and progesterone receptors and HER-2 by breast cancer cells].
    Zaĭrat'iants OV; Kolobov SV; Akopian IG; Opalenov KV; Barsanova TG
    Arkh Patol; 2004; 66(5):9-12. PubMed ID: 15575377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
    Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
    Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
    Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?
    Bird PA; Hill AG; Houssami N
    Ann Surg Oncol; 2008 Jul; 15(7):1983-8. PubMed ID: 18408976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
    Jalava P; Kuopio T; Huovinen R; Laine J; Collan Y
    Anticancer Res; 2005; 25(3c):2535-42. PubMed ID: 16080489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.